Correlation Between Deciphera Pharmaceuticals and Collegium Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Deciphera Pharmaceuticals and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deciphera Pharmaceuticals and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Deciphera Pharmaceuticals LLC and Collegium Pharmaceutical, you can compare the effects of market volatilities on Deciphera Pharmaceuticals and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deciphera Pharmaceuticals with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deciphera Pharmaceuticals and Collegium Pharmaceutical.
Diversification Opportunities for Deciphera Pharmaceuticals and Collegium Pharmaceutical
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Deciphera and Collegium is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Deciphera Pharmaceuticals LLC and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Deciphera Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deciphera Pharmaceuticals LLC are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Deciphera Pharmaceuticals i.e., Deciphera Pharmaceuticals and Collegium Pharmaceutical go up and down completely randomly.
Pair Corralation between Deciphera Pharmaceuticals and Collegium Pharmaceutical
Given the investment horizon of 90 days Deciphera Pharmaceuticals LLC is expected to under-perform the Collegium Pharmaceutical. In addition to that, Deciphera Pharmaceuticals is 1.36 times more volatile than Collegium Pharmaceutical. It trades about -0.01 of its total potential returns per unit of risk. Collegium Pharmaceutical is currently generating about 0.04 per unit of volatility. If you would invest 2,240 in Collegium Pharmaceutical on August 27, 2024 and sell it today you would earn a total of 756.00 from holding Collegium Pharmaceutical or generate 33.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 31.85% |
| Values | Daily Returns |
Deciphera Pharmaceuticals LLC vs. Collegium Pharmaceutical
Performance |
| Timeline |
| Deciphera Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Collegium Pharmaceutical |
Deciphera Pharmaceuticals and Collegium Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Deciphera Pharmaceuticals and Collegium Pharmaceutical
The main advantage of trading using opposite Deciphera Pharmaceuticals and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deciphera Pharmaceuticals position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.| Deciphera Pharmaceuticals vs. ANI Pharmaceuticals | Deciphera Pharmaceuticals vs. Phibro Animal Health | Deciphera Pharmaceuticals vs. Prestige Brand Holdings | Deciphera Pharmaceuticals vs. Evotec SE ADR |
| Collegium Pharmaceutical vs. Phibro Animal Health | Collegium Pharmaceutical vs. ANI Pharmaceuticals | Collegium Pharmaceutical vs. Procaps Group SA | Collegium Pharmaceutical vs. Amphastar P |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| CEOs Directory Screen CEOs from public companies around the world |